home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

Industry Advisers

Set up in December 2009, EPC’s board of Industry Advisers help develop the content of the magazine, using first-hand experience to keep the magazine focused on the latest developments in the industry.

Anne Maria Ylisaari
Senior Manager, Global Clinical Alliances & Sourcing
Orion Pharma Development

Beatrijs Van Liedekerke
Director, Advisory Services

Henrietta Ukwu
Senior Vice President, Global Regulatory Affairs
PPD, Inc

Jane Clarke
Director, eTMF Document Solutions and System Development

For further information please contact:

Jonathan Smith

Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

View the digital version of EPC

Featured in this issue
Marketplace & Business
CRO Marketplace

Value Added

Adam M Dion
at GlobalData suggests that accomodating a diverse range of clients is the best solution to challenges facing contract research organisations - companies are now offering new services to increase revenue and appeal to firms which are set to lead future innovation.

Competence Verification

Standard of Care

Martin Robinson
at the International Academy of Clinical Research outlines the findings from a recent report highlighting the need to readdress patient requirements and increase the public's protection. He reasons that competence verification could remedy the issues.

Serialisation Programs

Bigger Data

Ramesh J Chougule of Infosys explains how implementing a new serialisation program – and moving away from traditional data tracking methods – can translate into improved efficiency, precision and cost-saving.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December
Banner of PCI.EPC on Samedan
Banner of Samedan app.EPC on Samedan
Banner of TBM.EPC on Samedan
Industry Events

Cancer Drug Discovery & Preclinical Development 2014

17-18 September 2014, London, UK

ACI’s Cancer Drug Discovery & Preclinical Development conference takes place in London, UK on 17th & 18th September 2014. This keystone event will focus on the early stages of cancer drug research, with interactive debate and detailed presentations on a wide range of topics. A diverse range of academic and industry experts will be there to ensure fair and balanced coverage of the latest developments in the field.
More info >>

News and Press Releases

Samedan app – now available!

Samedan Ltd has launched a new app for iPhone and iPad, bringing together the digital editions of its six market-leading titles.
More info >>

air transport logo


White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement